Obidoxime

Obidoxime

Clinical data
ATC code	V03AB13 (WHO)
Pharmacokinetic data
Excretion	Renal
Identifiers
IUPAC name 1,1'-[oxybis(methylene)]bis{4-[(E)- (hydroxyimino)methyl]pyridinium}
CAS Number	114-90-9 N
PubChem CID	5485192
ChemSpider	4588647 Y
UNII	N6KNE1QA9O
ChEMBL	ChEMBL291233 N
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C14H16N4O3+2
Molar mass	288.302 g/mol
3D model (JSmol)	Interactive image
SMILES O=[NH+]\C=C1\C=C/N(/C=C1)COCN/2/C=C\C(C=C\2)=C\[NH+]=O
InChI InChI=1S/C14H14N4O3/c19-15-9-13-1-5-17(6-2-13)11-21-12-18-7-3-14(4-8-18)10-16-20/h1-10H,11-12H2/p+2 Y Key:HIGRLDNHDGYWQJ-UHFFFAOYSA-P Y
NY (what is this?)  (verify)

WikiDoc Resources for Obidoxime
Articles
Most recent articles on Obidoxime Most cited articles on Obidoxime Review articles on Obidoxime Articles on Obidoxime in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Obidoxime Images of Obidoxime Photos of Obidoxime Podcasts & MP3s on Obidoxime Videos on Obidoxime
Evidence Based Medicine
Cochrane Collaboration on Obidoxime Bandolier on Obidoxime TRIP on Obidoxime
Clinical Trials
Ongoing Trials on Obidoxime at Clinical Trials.gov Trial results on Obidoxime Clinical Trials on Obidoxime at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Obidoxime NICE Guidance on Obidoxime NHS PRODIGY Guidance FDA on Obidoxime CDC on Obidoxime
Books
Books on Obidoxime
News
Obidoxime in the news Be alerted to news on Obidoxime News trends on Obidoxime
Commentary
Blogs on Obidoxime
Definitions
Definitions of Obidoxime
Patient Resources / Community
Patient resources on Obidoxime Discussion groups on Obidoxime Patient Handouts on Obidoxime Directions to Hospitals Treating Obidoxime Risk calculators and risk factors for Obidoxime
Healthcare Provider Resources
Symptoms of Obidoxime Causes & Risk Factors for Obidoxime Diagnostic studies for Obidoxime Treatment of Obidoxime
Continuing Medical Education (CME)
CME Programs on Obidoxime
International
Obidoxime en Espanol Obidoxime en Francais
Business
Obidoxime in the Marketplace Patents on Obidoxime
Experimental / Informatics
List of terms related to Obidoxime

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Obidoxime is a member of the oxime family used to treat nerve gas poisoning. Oximes are drugs known for their ability to reverse the binding of organophosphorus compounds to the enzyme acetylcholinesterase (AChE).

AChE is an enzyme that removes acetylcholine from the synapse after it creates the required stimulation on the next nerve cell. If it gets inhibited, acetylcholine is not removed after the stimulation and multiple stimulations are made, resulting in muscle contractions and paralysis.

Organophosphates (such as nerve gases) are well-known inhibitors of AChE. They bind to a specific place on the enzyme and prevent it from functioning normally by changing the OH group on the serine residue and by protonating (quaternary nitrogen, R₄N⁺) the nearby nitrogen atom located in the histidine residue.

Function

Oximes such as obidoxime, pralidoxime and asoxime (HI-6) are used to restore enzyme functionality. They have greater affinity for the organic phosphate residue than the enzyme and they remove the phosphate group, restore the OH to serine and turn nitrogen from histidine back into its R₃N form (tertiary nitrogen). This results in full enzyme recovery and the phosphate-oxime compound is eliminated from the organism via urine.

Side effects

Oximes like these do have side effects and they include liver damage, kidney damage, nausea, vomiting, but they are very efficient antidotes to nerve gas poisoning. Usually treatment of poisoning includes the use of atropine, which can slow down the action of the poison, giving more time to apply the oxime.